BIO-Europe® 2024

Published on Ajouter cet évènement dans mon calendrier
Évènement partenaire

BIO-Europe® 2024 – 30th Annual International Partnering Conference

Your gateway to the global biopharma community

Date & locations:

November 4-6, 2024 | Stockholm, Sweden

November 12–13, 2024 | Digital Partnering

The 30th annual BIO-Europe will take place November 4-6, 2024 in Stockholm, Sweden, and it will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event.

Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.

BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programmes, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.

EBD Group continues to be committed to providing a forum for the entire global biopharma community to come together. As part of this commitment, two days of digital partnering are offered in the week following the in-person event.

BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization (BIO).

Request your promo code as soon as possible by contacting our DOO, Cécile ROUSSELOT

Registration is open here :

For more information and online registration please visit our conference website at :


  • Biotechnology, pharmaceutical, life science


  • partnering, business development, biotech, start-up, pharmaceutical, medical device, diagnostic, licensing, finance, life science, healthtech

Intended For:

Top executives from :

  • Established and emerging biotech companies
  • Pharmaceutical companies
  • Institutional financial firms
  • Private investors including venture capital and private equity firms
  • Related service companies

Retour aux évènements